Tyra Biosciences, Inc. TYRA Stock
Tyra Biosciences, Inc. Price Chart
Tyra Biosciences, Inc. TYRA Financial and Trading Overview
| Tyra Biosciences, Inc. stock price | 32.67 USD |
| Previous Close | 33.01 USD |
| Open | 32.8 USD |
| Bid | 23.45 USD x 200 |
| Ask | 39.94 USD x 200 |
| Day's Range | 31.09 - 33.27 USD |
| 52 Week Range | 9.96 - 40.65 USD |
| Volume | 983.31K USD |
| Avg. Volume | 963.66K USD |
| Market Cap | 1.95B USD |
| Beta (5Y Monthly) | 0.764 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.18 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 51.97 USD |
TYRA Valuation Measures
| Enterprise Value | 1.57B USD |
| Trailing P/E | N/A |
| Forward P/E | -11.616483 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 6.786158 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -11.027 |
Trading Information
Tyra Biosciences, Inc. Stock Price History
| Beta (5Y Monthly) | 0.764 |
| 52-Week Change | 221.73% |
| S&P500 52-Week Change | 20.51% |
| 52 Week High | 40.65 USD |
| 52 Week Low | 9.96 USD |
| 50-Day Moving Average | 31.6 USD |
| 200-Day Moving Average | 27.4 USD |
TYRA Share Statistics
| Avg. Volume (3 month) | 963.66K USD |
| Avg. Daily Volume (10-Days) | 1.02M USD |
| Shares Outstanding | 59.47M |
| Float | 30.88M |
| Short Ratio | 10.11 |
| % Held by Insiders | 2.85% |
| % Held by Institutions | 111.63% |
| Shares Short | 11.92M |
| Short % of Float | 37.07% |
| Short % of Shares Outstanding | 20.05% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -23.64% |
| Return on Equity (ttm) | -36.87% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -142368992 USD |
| Net Income Avi to Common (ttm) | -131105000 USD |
| Diluted EPS (ttm) | -2.18 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 383.47M USD |
| Total Cash Per Share (mrq) | 6.45 USD |
| Total Debt (mrq) | 5.7M USD |
| Total Debt/Equity (mrq) | 1.47 USD |
| Current Ratio (mrq) | 20.493 |
| Book Value Per Share (mrq) | 4.826 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -102255000 USD |
| Levered Free Cash Flow (ttm) | -60137752 USD |
Profile of Tyra Biosciences, Inc.
| Country | United States |
| State | CA |
| City | Carlsbad |
| Address | 2656 State Street |
| ZIP | 92008 |
| Phone | 619 728 4760 |
| Website | https://tyra.bio |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 87 |
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions. Its lead product candidate is FGFR3, which is in clinical trials for the treatment of patients with metastatic urothelial carcinoma and other solid tumors. The company is also developing TYRA-300 for skeletal conditions, including achondroplasia, hypochondroplasia, dysplasia, and other FGFR3-driven genetic syndromes; TYRA-200, a candidate in clinical trial for intrahepatic cholangiocarcinoma; and TYRA-430 for the treatment of hepatocellular carcinoma. Tyra Biosciences, Inc. was incorporated in 2018 and is headquartered in Carlsbad, California.
Q&A For Tyra Biosciences, Inc. Stock
What is a current TYRA stock price?
Tyra Biosciences, Inc. TYRA stock price today per share is 32.67 USD.
How to purchase Tyra Biosciences, Inc. stock?
You can buy TYRA shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Tyra Biosciences, Inc.?
The stock symbol or ticker of Tyra Biosciences, Inc. is TYRA.
Which industry does the Tyra Biosciences, Inc. company belong to?
The Tyra Biosciences, Inc. industry is Biotechnology.
How many shares does Tyra Biosciences, Inc. have in circulation?
The max supply of Tyra Biosciences, Inc. shares is 59.47M.
What is Tyra Biosciences, Inc. Price to Earnings Ratio (PE Ratio)?
Tyra Biosciences, Inc. PE Ratio is now.
What was Tyra Biosciences, Inc. earnings per share over the trailing 12 months (TTM)?
Tyra Biosciences, Inc. EPS is -2.18 USD over the trailing 12 months.
Which sector does the Tyra Biosciences, Inc. company belong to?
The Tyra Biosciences, Inc. sector is Healthcare.
Tyra Biosciences, Inc. TYRA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25873.18 USD — |
-1.55
|
6.31B USD — | 25822.1 USD — | 26139.37 USD — | — - | 6.31B USD — |
|
US Tech Global Select Market Com
NQGS
US
|
12700.6 USD — |
-1.53
|
— — | 12675.61 USD — | 12830.27 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1254.95 USD — |
-1.05
|
— — | 1250.11 USD — | 1262.34 USD — | — - | — — |
- {{ link.label }} {{link}}